First Citizens Financial Corp bought a new position in CME Group Inc. (NASDAQ:CME – Free Report) during the third quarter, according to its most recent disclosure with the SEC. The firm bought 3,388 shares of the financial services provider’s stock, valued at approximately $888,000.
Several other institutional investors and hedge funds also recently bought and sold shares of CME. CX Institutional raised its stake in shares of CME Group by 137.1% in the third quarter. CX Institutional now owns 5,354 shares of the financial services provider’s stock worth $1,403,000 after buying an additional 3,096 shares during the period. Planning Strategies Inc. increased its holdings in CME Group by 1,528.6% in the 3rd quarter. Planning Strategies Inc. now owns 228 shares of the financial services provider’s stock worth $60,000 after acquiring an additional 214 shares in the last quarter. Burkett Financial Services LLC purchased a new stake in CME Group in the 3rd quarter worth approximately $62,000. Envestnet Portfolio Solutions Inc. raised its stake in CME Group by 16.6% during the 2nd quarter. Envestnet Portfolio Solutions Inc. now owns 70,325 shares of the financial services provider’s stock worth $14,809,000 after acquiring an additional 10,005 shares during the period. Finally, Andra AP fonden raised its stake in CME Group by 91.5% during the 2nd quarter. Andra AP fonden now owns 91,990 shares of the financial services provider’s stock worth $20,314,000 after acquiring an additional 43,960 shares during the period. 87.75% of the stock is currently owned by hedge funds and other institutional investors.
CME Group Price Performance
CME traded down $1.96 during trading on Friday, reaching $263.14. 1,498,201 shares of the company traded hands, compared to its average volume of 2,543,817. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02. CME Group Inc. has a 12-month low of $218.31 and a 12-month high of $329.16. The firm has a fifty day simple moving average of $270.88 and a 200 day simple moving average of $272.63. The company has a market cap of $94.62 billion, a P/E ratio of 22.32, a PEG ratio of 3.10 and a beta of 0.24.
CME Group Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Friday, September 25th. Shareholders of record on Wednesday, September 9th were issued a $1.30 dividend. This represents a $5.20 dividend on an annualized basis and a yield of 2.0%. The ex-dividend date was Wednesday, September 9th. CME Group’s payout ratio is currently 44.11%.
Insider Buying and Selling at CME Group
In other news, CEO Terrence A. Duffy sold 15,000 shares of the firm’s stock in a transaction dated Thursday, September 10th. The stock was sold at an average price of $274.44, for a total transaction of $4,116,600.00. Following the completion of the transaction, the chief executive officer owned 40,630 shares in the company, valued at $11,150,497.20. This trade represents a 26.96% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Elizabeth A. Cook sold 500 shares of CME Group stock in a transaction dated Monday, September 14th. The stock was sold at an average price of $280.11, for a total value of $140,055.00. Following the completion of the sale, the director directly owned 17,916 shares in the company, valued at $5,018,450.76. This trade represents a 2.72% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 0.30% of the stock is currently owned by insiders.
Key CME Group News
Here are the key news stories impacting CME Group this week:
- Positive Sentiment: Record trading activity supports revenue prospects: CME Group reported September and third-quarter average daily volume records, with ADV rising 22% year over year in September and 16% for the quarter. Higher volumes generally increase clearing and transaction revenue. CME Group Sets September, Q3 Average Daily Volume Records
- Positive Sentiment: Strong soybean futures participation: CME Group set a new open-interest record in soybean futures, indicating continued engagement in agricultural derivatives and supporting the exchange’s diversified volume base. CME Group Sets New Open Interest Record in Soybean Futures
- Positive Sentiment: Third-quarter earnings expectations remain favorable: Analysts anticipate low double-digit bottom-line growth when CME Group reports third-quarter results later this month, helped by the elevated trading volumes. What You Need to Know Ahead of CME Group’s Earnings Release
- Neutral Sentiment: Investor commentary highlights a volume-versus-price disconnect: Cambiar Investors’ quarterly letter discussed CME Group as a potential addition on weakness, noting that record trading activity has not translated into comparable stock performance. This may attract value-oriented investors but also underscores market hesitation. CME Group Adding on Weakness
- Negative Sentiment: Valuation may limit near-term upside: An analysis asked whether CME Group is fully priced following its push into cryptocurrency futures, suggesting investors may need additional growth or execution evidence to justify further appreciation. Is CME Group Fully Priced After Its Crypto Futures Push?
- Negative Sentiment: Analyst rating adds pressure: Wall Street analysts recently assigned CME Group a “Hold” rating, reinforcing the view that the stock’s strong operating performance may already be reflected in its valuation. CME Group Stock Rated Hold
Wall Street Analyst Weigh In
Several equities analysts have weighed in on CME shares. Wells Fargo & Company started coverage on shares of CME Group in a report on Thursday. They set an “overweight” rating and a $301.00 price target on the stock. Piper Sandler decreased their price objective on shares of CME Group from $329.00 to $295.00 and set an “overweight” rating on the stock in a research report on Wednesday, July 15th. Weiss Ratings cut shares of CME Group from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Tuesday, August 11th. Wall Street Zen raised shares of CME Group from a “strong sell” rating to a “sell” rating in a report on Saturday, August 29th. Finally, Raymond James Financial reiterated an “outperform” rating and issued a $320.00 price target on shares of CME Group in a research note on Thursday, July 2nd. Nine investment analysts have rated the stock with a Buy rating, six have given a Hold rating and three have given a Sell rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $289.81.
View Our Latest Stock Report on CME Group
CME Group Company Profile
CME Group Inc operates global derivatives marketplaces that enable customers to manage risk and trade futures and options contracts. Its exchanges offer products linked to interest rates, equity indexes, foreign currencies, agricultural commodities, energy, metals and other asset classes.
The company also provides central counterparty clearing, settlement and related risk-management services for transactions conducted on its markets. In addition, CME Group offers market data, benchmark products and technology services that support trading, analysis and connectivity for financial institutions, businesses, professional traders and other market participants.
CME Group’s history includes the Chicago Board of Trade, founded in 1848, and the Chicago Mercantile Exchange, established in 1898.
Featured Articles
- Five stocks we like better than CME Group
- AST SpaceMobile’s BlueBird Progress Comes With Several Risks Still Unresolved
- Time to Nibble on MCD Stock After it Enters Oversold Territory?
- McCormick Stock Trades Cheap, Offers Dividend Growth and Unilever Deal Upside
- Corning and AT&T’s $3 Billion Fiber Deal Reveals Where AI Spending Goes Next
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.
